A homozygous point mutation in the <i>Mrps34</i> gene causes a decrease in the MRPS34 protein. by Tara R. Richman (713532)

“…The 5′- and 3′-untranslated regions are shown as grey boxes and the predicted mitochondrial targeting sequence is shown as a black box (predicted using MitoProtII, [<a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1005089#pgen.1005089.ref040" target="_blank">40</a>]). …”

Lung cancer cell lines secrete BMP2 and knockdown of BMP2 decreases BMP signaling and induces cell death. by Elaine Langenfeld (402034)

“…(<b>D</b>) Western blot analysis of H1299 cells in SFM 48 hours after being transfected with control siRNA or siRNA targeting BMP2. BMP2 knockdown causes a decrease in expression of pSmad 1/5 and Id1. …”

BH₄ bioavailability was decreased in cortical and hippocampal microvessels as compared to microvessels from the cerebellum. by Susan A. Austin (768265)

<i>Dmd^mdx</i> rats are characterized by muscle weakness and by a decrease in a spontaneous activity. by Thibaut Larcher (331981)

“…<i>Dmd^mdx</i> rats showed fatigue with a decreased force grip across the five pulls, and significant values are obtained for the two last trials that were reduced to ∼70% when compared to Trial 1. …”

PLCε lacking the CDC25 domain and lipase activity cannot rescue monolayer integrity and decreased active Rap1 levels. by Peter V. DiStefano (3111639)

The decreasing rates of V_p with temperature. by Nazlı Tunar Özcan (14833635)

“…In this study, P-wave velocity (V_p), Brazilian tensile strength (σ_t), uniaxial compression strength (σ_c) of Çankırı rock salt were investigated under different temperatures ranging from 20°C to 250°C since the temperature is a factor that causes changes in some physical and geo-mechanical properties of rocks. …”

METH decreased basal pERK1/2 levels and potentiated ERK1/2 phosphorylation induced by 6-OHDA. by Amina El Ayadi (341955)

“…METH decreased activation of ERK 1/2 in a concentration-dependent manner (0, 0.5, and 1 mM at the 24 hr time point) and enhanced the activation of ERK1/2 after 6-OHDA exposure. …”

Resveratrol decreased intracellular levels of R5P. by Mohd Askandar Iqbal (324124)

“…<p>R5P is a pentose phosphate pathway intermediate, an important marker for anabolism (nucleotide biosynthesis). …”

Decreased Tks5 expression results in neural crest-derived defects. by Danielle A. Murphy (212554)

“…<p>(A–B) Melanophores within the trunk region above the yolk sac extension in control MO-injected and Tks5 MO-injected embryos were qualitatively (A) and quantitatively (B) analyzed. n = 15 embryos and SEM is shown by bar. p values obtained from Student's t-test. ** denotes p<0.01. …”

Decreased insulin-stimulated glucose uptake and Akt phosphorylation in myotubes from severely obese donors with type 2 diabetes. by Siril S. Bakke (705734)

Pretreatment of β-cells with recombinant CXCL12 improves viability and induces a decrease in PARP-1 activity. by Nevena Grdović (394542)

M2 macrophages decrease alkaline phosphatase activity through Wnt signalling pathways. by Jesús Cosín-Roger (123861)

Phosphorus application reduces aluminum toxicity in two <i>Eucalyptus</i> clones by increasing its accumulation in roots and decreasing its content in leaves - Fig 5 by Weichao Teng (4760163)

DPPIV inhibitor MK626 decreases T1D incidence and reduces the insulitis score in NOD mice. by Núria Alonso (824191)

Rdh10a deficient embryos have decreased expression of RA signaling responsive genes. by Enrico D’Aniello (798447)

“…<p>(A-F) ISH for <i>cyp26a1</i>, <i>hoxb5b</i>, <i>and dhrs3a</i> expression in control sibling and Rdh10a deficient embryos. …”

Corticosterone treatment decreases MMP-2 promoter activity. by Eric A. Shikatani (131260)

“…MMP-2 mRNA levels were decreased with corticosterone treatment (A) (p = 0.006, n = 5). …”

Mutation of Thr235 to alanine decreases sumoylation of C/EBPbeta1. by Allison A. Atwood (343105)

Astrocytic marker was decreased in the brain of prenatally saline-exposed offspring, but not in the offspring prenatally exposed to LPS, following pharmacological activation of mGl... by Dany Arsenault (229311)

The blood plasma, kidney, and brain concentration levels (ng/ml) of GSK360A presented for 5 and 24 hours after GSK360A (30 mg/kg) was administered orally by gavage. by Jin Zhou (90734)

Modulating effect of adenosine (Ado) on TNFα-induced decrease in markers of mitochondrial mass. by Theodore J. Kalogeris (575591)